))
A Rheumatologist's Perspective on Prior Authorization and Timely Access to Treatments
Manage episode 423635869 series 2937016
المحتوى المقدم من Simplify Prior Authorization. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Simplify Prior Authorization أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
In this episode of the Simplify Prior Authorization podcast series Denise Balch once again speaks to Dr. Imtiaz Khan, a licensed rheumatologist in Canada and the U.S. Dr. Khan is the former Head of Rheumatology at The Mississauga Hospital and is now in private practice and continues to be active in clinical research. Dr. Khan became Chair of the Ontario Rheumatologists Association (ORA) Private Payers committee in 2019.
Dr. Khan shares his insights into how new developments in the treatment of rheumatoid arthritis are changing patient treatment, including the introduction of biosimilars and new small molecules taken orally known as Janus kinase (JAK) inhibitors. He speaks to the efficiencies the electronic specialty authorization claims process for public payers in Ontario (SADIE) has created, and opportunities for the private sector to benefit from electronic prior authorization to ease the administrative burden and patient wait times without compromising drug cost management.
13 حلقات
مشاركة
